These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of transforming growth factor-beta/Smad signaling by phosphatidylinositol 3-kinase pathway. Qiao J; Kang J; Ko TC; Evers BM; Chung DH Cancer Lett; 2006 Oct; 242(2):207-14. PubMed ID: 16412560 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells. Qiao L; Paul P; Lee S; Qiao J; Wang Y; Chung DH Biochem Biophys Res Commun; 2013 May; 435(2):295-9. PubMed ID: 23618860 [TBL] [Abstract][Full Text] [Related]
8. Gastrin-releasing peptide is a growth factor for human neuroblastomas. Kim S; Hu W; Kelly DR; Hellmich MR; Evers BM; Chung DH Ann Surg; 2002 May; 235(5):621-9; discussion 629-30. PubMed ID: 11981207 [TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas. Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019 [TBL] [Abstract][Full Text] [Related]
10. The effects of clozapine on the GSK-3-mediated signaling pathway. Kang UG; Seo MS; Roh MS; Kim Y; Yoon SC; Kim YS FEBS Lett; 2004 Feb; 560(1-3):115-9. PubMed ID: 14988008 [TBL] [Abstract][Full Text] [Related]
12. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells. Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515 [TBL] [Abstract][Full Text] [Related]
13. Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway. Clarimundo VS; Farinon M; Pedó RT; Teixeira VON; Nör C; Gulko PS; Xavier RM; de Oliveira PG Peptides; 2017 Sep; 95():57-61. PubMed ID: 28733141 [TBL] [Abstract][Full Text] [Related]
14. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma. Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162 [TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway. Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase C regulates bombesin-induced rapid VEGF secretion in neuroblastoma cells. Schlegel C; Paul P; Lee S; Kim KW; Colon N; Qiao J; Chung DH Anticancer Res; 2012 Nov; 32(11):4691-6. PubMed ID: 23155231 [TBL] [Abstract][Full Text] [Related]
17. Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling. Paul P; Qiao J; Kim KW; Romain C; Lee S; Volny N; Mobley B; Correa H; Chung DH PLoS One; 2013; 8(9):e72570. PubMed ID: 24039782 [TBL] [Abstract][Full Text] [Related]
18. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500 [TBL] [Abstract][Full Text] [Related]
19. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865 [TBL] [Abstract][Full Text] [Related]
20. PI3K signaling mediates diverse regulation of ATF4 expression for the survival of HK-2 cells exposed to cadmium. Fujiki K; Inamura H; Matsuoka M Arch Toxicol; 2014 Feb; 88(2):403-14. PubMed ID: 24057571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]